Protein features in PepsiCo’s portfolio push in both snacks and beverages to embrace consumer interest in health.

CEO Ramon Laguarta said the Doritos maker hasn’t seen a “direct impact” from GLP-1 medications despite a higher level of awareness among consumers toward health and wellness.

PepsiCo ended the fiscal year 2024 with further declines in its snack business with five back-to-back quarters of volume ...

Food and beverage giant PepsiCo (PEP) slightly missed on fourth quarter revenue estimates, illustrating a mixed sales picture ...

"We're not immune to this [tariffs] — we are less impacted than most of the businesses," PepsiCo chair and CEO Ramon Laguarta ...

PepsiCo (PEP) , which owns popular food and drink brands such as Pepsi, Lay’s, Gatorade, Tostitos, and many others, recently ...

PepsiCo's snack food and beverage volumes both climbed 1% globally in the fourth quarter, with strong growth in Africa and ...

Beverage and snack maker PepsiCo (PEP) is taking a cautious approach to the next 12 months due to concerns over tariffs and ...

Management issued low single-digit organic sales growth guidance for 2025, reflecting a cautious stance amid global uncertainty and geopolitical factors. They anticipate gradual improvement in North ...

Analyzing PepsiCo, Inc.'s stock drop, financial health, and growth strategies, highlighting a buying opportunity for ...

PepsiCo achieved double-digit organic revenue growth in India for 2024, supported by gains in savoury snacks and beverages.

PepsiCo stock is lower Tuesday after the soft drink maker's top-line miss offsets an earnings beat and dividend hike. Here's ...